EXTAVIA

Novartis AG

Application Filed: 2006-03-29

Trademark Application Details

Status

800

Live/Registered

REGISTERED AND RENEWED

Research	OneLook Acronym Finder
Serial Number	78848819
Registration Number	3181020
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Novartis Pharmaceuticals Corporation
Attorney Name	Maury M. Tepper, III
Attorney Docket Number	51653.
Law Office Assigned	M70
Employee Name	KING, LINDA M

Timeline

2006-03-29	Application Filed
2006-09-19	Published for Opposition
2006-12-05	Trademark Registered
2016-11-30	Location: GENERIC WEB UPDATE
2016-11-30	Status: Live/Registered
2016-12-05	Renewal Date
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Novartis AG
Address	CH-4002 Basel CH
Legal Entity Type	Corporation
Legal Entity State	CH

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Maury M. Tepper, III
TEPPER & EYSTER, PLLC
3724 BENSON DRIVE
RALEIGH NC 27609

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system [, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines ]

Type Code

Type

GS0051

Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system [, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines ]

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2006-04-04	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2006-06-26	2 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2006-07-03	3 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2006-07-03	4 GNRT F:First Action
EXAMINERS AMENDMENT -WRITTEN	2006-07-11	5 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2006-07-11	6 GNEA O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2006-07-11	7 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2006-07-11	8 CNSA O:Outgoing Correspondence
ASSIGNED TO LIE	2006-07-14	9 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2006-07-25	10 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2006-08-30	11 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2006-09-19	12 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2006-12-05	13 R.PR A:Allowance for Publication
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2009-06-25	14 TCCA I:Incoming Correspondence
TEAS SECTION 8 RECEIVED	2012-11-13	15 ES8R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2012-12-13	16 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (6-YR) ACCEPTED	2012-12-13	17 8.OK O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED	2012-12-13	18 NAS8 E:E-Mail
TEAS SECTION 15 RECEIVED	2015-01-19	19 E15R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2015-01-20	20 APRE A:Allowance for Publication
REGISTERED - SEC. 15 ACKNOWLEDGED	2015-01-20	21 15AK O:Outgoing Correspondence
SEC. 15 ACKNOWLEDGEMENT - E-MAILED	2015-01-20	22 NA15 E:E-Mail
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED	2015-12-05	23 REM2 E:E-Mail
TEAS SECTION 8 & 9 RECEIVED	2016-09-16	24 E89R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2016-11-29	25 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED	2016-11-30	26 89AG O:Outgoing Correspondence
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)	2016-11-30	27 RNL1 Q:
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED	2016-12-01	28 NA89 E:E-Mail

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
EXTAVIA 85418581 4543851 Live/Registered	Novartis AG 2011-09-09
EXTAVIA 85418577 4535484 Live/Registered	Novartis AG 2011-09-09
EXTAVIA 78848819 3181020 Live/Registered	Novartis AG 2006-03-29
EXTAVIA 78221165 2813082 Dead/Cancelled	Novartis AG 2003-03-04
EXTAVIA 78140688 2853387 Dead/Cancelled	Novartis AG 2002-07-02
EXTAVIA 77384067 not registered Dead/Abandoned	Novartis AG 2008-01-30
EXTAVIA 75685030 not registered Dead/Abandoned	Novartis AG 1999-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.